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The management of aortic reconstruction for an
aortic injury in a contaminated field is controversial.1
Repair with autogenous material is the most common
technique for handling an arterial injury in a contam-
inated field. Commonly used autogenous grafts
include long saphenous and superficial femoral veins.
The use of extraanatomic grafting methods is an alter-
native choice, which is usually dictated by anatomic
circumstances, eg, extensive injuries. However, its
long-term patency may not be as favorable, and sub-
sequent revascularization may be necessary. 
Use of the inferior vena cava for an injured aorta
has not been recommended, because of the hemody-
namic changes and acute lower limb venous hyper-
tension that would arise if the cava were not replaced.
An unusual case of successful in situ reconstruction of
the aorta in a contaminated field with the infrarenal
inferior vena cava was studied. 
CASE REPORT
The patient was a 38-year-old man with no significant
medical history who presented with an abdominal and right
testicular mass. His alpha-fetoprotein level was 8,500 m g/L
(range, 0 to 11 m g/L) and his beta human chorionic
gonadotrophin level was 545 IU/L (range, 0 to 5 IU/L).
He underwent right inguinal orchidectomy, which con-
firmed a testicular tumor, with 70% of the tumor being
yolk-sac tumor, 20% embryonal cell carcinoma, and 10%
immature teratoma. Four cycles of chemotherapy, consist-
ing of ifosfamide, etoposide, and cisplatin, were given. He
tolerated this well, and the tumor markers returned to ref-
erence range. However, the abdominal mass did not shrink
completely. A residual retroperitoneal tumor mass, 7 cm in
diameter, below the renal hilum, compressing the inferior
vena cava (IVC) and surrounding the aorta, was revealed by
means of a subsequent computed tomography (CT) scan
(Fig 1). There were no other sites of metastatic disease. 
Laparotomy for resection of the residual disease was
planned with curative intent. The patient had neither
symptoms nor signs of IVC obstruction. Before the
planned exploration, he started to vomit repeatedly
because of duodenal obstruction from the retroperitoneal
tumor. At laparotomy, the retroperitoneal tumor mass was
found to be adherent to the duodenum, causing partial
obstruction. The tumor also surrounded the IVC, causing
chronic compression, and was densely adherent to the
adventitia of the aorta. During dissection of the tumor off
the duodenum, the duodenum was inadvertently entered.
It was apparent that resection of part of the duodenum,
with the tumor, was needed for tumor clearance. There-
fore, a portion of the fourth part of the duodenum was
excised, and end-to-end anastomosis performed. 
Meanwhile, dissection of the tumor adjacent to the
aorta was continued. During the dissection, the adventitia
of the aorta was stripped of approximately 50% circumfer-
ence over a 6-cm length. This resulted in a large area of
injury in the infrarenal aorta. An aortic clamp was applied
to control bleeding. Vascular surgery was consulted imme-
diately. Primary repair with suture or vein patch angioplas-
ty was deemed impossible because of the friable aortic wall.
Aortic replacement was required. Because of the consider-
able contamination from the duodenal injury and resec-
tion, an in situ reconstruction with prosthetic graft was
deemed unsafe. The IVC, which had been chronically com-
pressed by the tumor, was dissected free from the tumor,
and the infrarenal IVC was harvested for use as an autoge-
nous graft. No gross tumor invasion of the IVC was appar-
ent. The IVC would have been left intact had it not been
harvested as an autogenous graft. A 6-cm segment of the
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injured infrarenal aorta was resected, and aortic recon-
struction with the harvested segment of IVC was per-
formed. The IVC was not reconstructed. Because of the
prolonged clamp time (3 hours), clinical evidence of com-
partment syndrome was apparent immediately after revas-
cularization. This required bilateral four-compartment fas-
ciotomies before conclusion of the operation. 
The patient recovered slowly from the operation, with all
lower limb peripheral pulses palpable. Subsequent skin graft-
ing was performed to cover the fasciotomy sites, and he was
discharged with no major functional disability. Pathologic
examination of the resected specimen revealed both viable
and necrotic nonseminomatous germ cell tumor. 
The patient remained well and was last seen 12 months
after laparotomy and aortic reconstruction. There was nei-
ther swelling nor any other venous abnormality in the
lower extremities, although compression stockings were
used. However, his tumor recurred, causing duodenal
obstruction and upper gastrointestinal bleeding. Tumor
recurrence over the retroperitoneal region superior and
anterior to the right kidney was shown by means of CT.
The aortic graft remained patent, with no evidence of
tumor involvement (Fig 2). Further chemotherapy with
paclitaxel was offered, with a plan for reexploration after
chemotherapy.
DISCUSSION
Radical retroperitoneal lymphadenectomy is the
recommended treatment in patients with residual
retroperitoneal disease after systemic chemotherapy
for nonseminal germ cell tumor of the testis.4 The dis-
section of the tumor can be extremely difficult when
the aortic adventitia is involved. Occasionally, aortic
injuries may occur. In situ replacement with autoge-
nous material is the most common technique for han-
dling an arterial injury, especially in a contaminated
field.3,5-7 To replace the aorta, reconstruction with
superficial femoral vein has been very successful.8
In situ replacement of the injured aorta with
prosthetic material is an alternative when primary
repair is not possible. However, in the presence of
significant contamination, this would not be advis-
able, because of the risk of subsequent graft infec-
tion. In this situation, an extraanatomic bypass graft-
ing procedure may be an alternative. Although this
has the advantage of avoiding graft placement in a
contaminated field, these bypass grafts may have less
favorable long-term patency rates, and subsequent
revascularization may be required.
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Fig 1. Computed tomography scan showing residual retroperitoneal tumor compressing the
inferior vena cava (single arrow) and surrounding the aorta (double arrow).
Other methods of aortic reconstruction, such as
the use of a saphenous spiral vein graft, have been
reported.9 But this procedure is technically demand-
ing, and progressive dilatation of the graft may occur,
leading to subsequent graft excision with prosthetic
graft replacement. Reconstruction with aortic allo-
graft is another possibility. Kieffer et al10 reported on
in situ allograft replacement of the infected infrarenal
aortic prosthetic grafts in 43 patients, with favorable
mortality and morbidity. However, this procedure
was limited by the availability of aortic allograft and
late allograft deterioration.10
Successful aortic reconstruction with an in situ
prosthetic graft in the presence of aortic sepsis has
also been reported.2 Wrapping a prosthetic graft
with vascularized tissue, such as a muscle flap, has
been proposed to further protect the graft from
infection, because increased oxygen delivery and
wound oxygen tension may improve leucocytic
activity and bacterial elimination.11 An omental flap
is another alternative, although the vascularity is less
than a muscle flap and carries the extra risk of inter-
nal herniation.11
The particular features of this case illustrate the
use of the infrarenal IVC as another alternative to
those methods of aortic reconstruction. This case
was unusual, because the IVC was already com-
pressed proximally and presumably venous pathways
were operative. In addition, it was more convenient
to harvest the contiguous IVC in the operative field,
rather than make a separate incision. 
Although an IVC graft has the advantages of
being a good size-match to the aorta and resistance
to infection, we cannot recommend its routine use
for situations of aortic injury in a contaminated field.
Typically, acute caval interruption without recon-
struction would lead to acute and massive fluid shifts
with subsequent hypotension and renal failure and
significant venous morbidity. Despite the use of rou-
tine hydration precautions and temporary IVC
occlusion before permanent interruption to mini-
mize these hemodynamic changes,12-14 we believe
that these injuries are best treated by autogenous
grafts (especially the superficial femoral vein), or
prosthetic grafts when there is no contamination.
Although autogenous venous grafts are resistant
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Fig 2. Follow-up computed tomography scan, 12 months after the operation, showing tumor
recurrence in the retroperitoneal region with a patent aortic graft (single arrow).
to infection,8 they can dissolve in the face of intraab-
dominal sepsis, especially when digestive enzymes
are present. The presentation can be that of sudden
fatal hemorrhage from graft disruption. Therefore, it
is vital to secure the duodenal repair, and the opera-
tive field should be thoroughly irrigated with saline. 
In summary, the IVC can be a potential source of
autogenous graft material. It may be a useful con-
duit for in situ aortic reconstruction in the presence
of infection or contamination, especially if it has
been chronically compressed preoperatively. 
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